20Slash20 Inc., the innovator behind The Eye Drink, has been featured in coverage of the Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference. The company is presenting its flagship product, The Eye Drink, described as the world’s first clinically inspired, ready-to-drink functional beverage specifically formulated to minimize ocular issues in today’s screen-heavy world.
The Eye Drink targets individuals who spend long hours daily staring at computer or cellphone screens, aiming to reduce screen-induced dry eyes and macular damage. The beverage leverages science-backed nutrients based on AREDS 2 Studies and includes vegan-friendly triglyceride-formed Omega-3 to protect visual performance and improve ocular comfort. By incorporating these ingredients into a convenient drink, 20Slash20 is modernizing preventive eyecare, transforming clinical science into a simple, delicious, and enjoyable daily habit.
The company distributes The Eye Drink through direct-to-consumer channels, professional medical affiliates, and natural product retail stores. This multi-channel approach positions 20Slash20 to reach a broad audience concerned with eye health in an era of increased digital device usage.
The Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference serves as a platform for emerging companies like 20Slash20 to connect with investors and industry professionals. Moody Capital Solutions Inc., the event’s organizer, is an independent, full-service investment bank with over 40 years of experience in capital raising, M&A, and advisory services, and is recognized as a market leader in rights offerings. The firm is a member of FINRA and SIPC.
The conference highlights disruptive growth and life sciences sectors, offering companies the opportunity to showcase innovations that could have significant market impact. 20Slash20’s participation underscores the growing intersection of consumer health products and clinical research, particularly in addressing health issues associated with modern digital lifestyles.
IBN, a multifaceted financial news and publishing company, is providing extensive coverage of the conference through a custom-built portal that includes summaries on each participating company. IBN aims to enhance visibility for these companies by using social media and syndicated articles, allowing investors to evaluate them efficiently via one-click access to market research tools and helpful website links.
IBN has a decade-long history of providing real-time coverage for numerous global events and conferences. Its syndication partners extend digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily, ensuring broad exposure for participating companies.
This coverage of 20Slash20 and the conference highlights the importance of innovation in preventive health, particularly as screen time continues to rise globally. The potential impact of The Eye Drink lies in its ability to offer a practical solution for ocular health, a growing concern for professionals, students, and anyone reliant on digital screens. The company’s approach could influence the functional beverage market and encourage further integration of clinical science into everyday consumer products.
For more details on the conference and participating companies, interested parties can access the Moody Capital conference page at https://moodycapital.com/conference/ and IBN’s coverage at https://ibn.fm/MoodyCapital2026Conference. Additional information about 20Slash20 and The Eye Drink is available at theeyedrink.com.
